63 Biggest Movers From Yesterday
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday.
36 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 46% to $21.13 after jumping around 35% on Wednesday.
MediWound Receives Additional $9M From BARDA For NexoBrid FDA Application Resubmission
The Biomedical Advanced Research and Development Authority (BARDA) will
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours:
MediWound Granted European Patent Titled ‘DEBRIDING COMPOSITION FOR TREATING WOUNDS’
https://data.epo.org/publication-server/pdf-document?pn=3408387&ki=B1&cc=EP
MediWound Announces Positive Initial Data From Its U.S. Phase 2 Pharmacology Study Of EscharEx Showing Effective And Rapid Debridement In Chronic And Hard To Heal Wounds
MediWound Ltd. (NASDAQ:MDWD) (the "Company"), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced positive
MediWound Completes Enrollment Of Its EscharEx U.S. Phase 2 Adaptive Design Study
MediWound Ltd. (NASDAQ:MDWD) (the “Company”), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced it has
MediWound Q3 EPS $(0.12) Beats $(0.13) Estimate, Sales $6.37M Beat $5.67M Estimate
MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 71.43 percent decrease over losses of $(0.07) per share from the same
Earnings Scheduled For November 16, 2021
Companies Reporting Before The Bell
• Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million.
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.